Google
 
Web cbwinfo.com
Home News History General Links Bookstore
Biological Gateway Chemical Gateway Radiological Gateway

Coccidioidomycosis:
essential data

Fungal weapon active against humans

Synopsis, Diagnosis, Symptoms,
Countermeasures, Properties and Uses, Terrorist Interest, IDC Codes

Safety Precautions for Casualties

Standard Precautions defined by the 1996 CDC guidelines should be adopted for handling patients. Contact precautions may be needed for patients with draining lesions.

Biosafety level 3 practices should be adopted for handling of samples.

 

Return to Top

Synopsis of Agent Properties

Causative organism: 
(Systematic name in 1997)
Coccidioides immitis
Classification: An arthrospore-forming filamentous fungus
belonging the mitosporic or imperfect fungi
(fungi with no known sexual stage).
Alternative disease names:
  • Coccidioidal granuloma
  • San Joaquin Valley fever
  • Valley fever
Return to Top

Key Diagnostic Tests.

The commonest symptoms are a dry cough, chest pain, headache, a dry rash that may develop into tender red nodules on the lower legs.

Differential Diagnosis

Other disease or conditions that need to be eliminated
Other infectious diseases Other problems
  • Pneumonia
  • Tuberculosis
  • Erythema nodosum
  • Lung cancer
  • Sarcoidosis
  • Sarcoma
  • Septic shock

 

Return to Top

Symptoms and effects. The disease is often mild and clears after a few weeks. After an incubation period of about a month dry cough, pleuritic chest pain, dypsnea (difficulty breathing), malaise, headache and a rash. In some case, especially Caucasian women, tender red nodules develop on the shins with joint pain in the knees and shins. A fever that lasts for several weeks is often the only symptom.

In more serious cases, the fungus disseminates through the body causing fever and abscesses. When the lungs are affected, tuberculosis-like lesions are developed and the patient will cough up blood.

Mortality is about 60% for sufferers of the disseminated form of the disease.

Return to Top

Medical and Physical Countermeasures.

Vaccination (Immunoprophylaxis)

A vaccine is not available.

 Specific Therapy

Antimycotics (amphotericin B, fluconazole and itoconazole) may be used. In severe cases intravenous administration may be necessary. In cases of coccidioidal meningitis, the drug may have to be administered directly into the spinal cord via a lumbar puncture.

Miconazole and ketoconazole suppress growth of the organism but do not kill it.

Supportive care

Decontamination

The fungus is killed by 1% sodium hypochlorite, phenolics, glutaraldehyde, and formaldehyde.

Return to Top

Agent Properties and Potential Uses

Spores of the fungus are hardy and can survive in dry soil for many years. They are easily spread as aerosols and by coughing. When inhaled, the spores grow into small speherules that fill with spores and then burst.

The disease is found in arid regions of the southwestern United States and is a common risk for agricultural workers. It is also a risk for immunocompromised patients who will need to take antimycotics for the rest of their lives if infected. Outbreaks often occur after earthquakes when spores resting in soil are thrown into the air by the violent ground movements.

Return to Top

Terrorist Acquisition and Attempted Use.

Return to Top

International Classification of Disease Codes
Disease ICD-9-CM ICD-10
Coccidioidomycosis 114 B38
Acute pulmonary coccidioidomycosis
B38.0
Chronic pulmonary coccidioidomycosis
B38.1
Primary coccidioidomycosis (pulmonary) 114.0 B38.2
Coccidiomycosis of the skin
B38.3
Primary extrapulmonary coccidioidomycosis 114.1
Coccidioidal meningitis 114.2 B38.4
Disseminated coccidiomycosis
B38.7
Other forms of progressive coccidioidomycosis 114.3 B38.8
Coccidioidomycosis, unspecified 114.9 B38.9

Copyright© 1999 CBWInfo.com

Home Copyright Disclaimer
Privacy
Feedback Sponsorship